Skip to content

About Us
- About Us
- Team
- Careers
- Investors
- Collaborations
Our Technology
- Our Technology
- Our Device
Applications
News
Contact Us

Menu

About Us
- About Us
- Team
- Careers
- Investors
- Collaborations
Our Technology
- Our Technology
- Our Device
Applications
News
Contact Us

News

August 30, 2022

Santersus AG in combination with their institutional partners our extremely proud to present the newest findings regarding the success in the Ex Vivo lung perfusion studies.

REMOVAL-OF-NEUTROPHIL-EXTRACELLULAR Download

Related links

About Santersus

https://www.santersus.com/

About VolitionRx Limited

https://www.volition.com/

If you would like to learn more about our technology, please contact Santersus team at info@santersus.com

Santersus AG continues to present the latest work across the globe, presenting at conferences in Berlin, Rotterdam, Athens, and Milan

November 14, 2023

Santersus AG presented at NHSBT Joint Congress, held by British Transplantation Society

March 26, 2023

Santersus AG presented at Apheresis Conference at the University of California San Diego

March 26, 2023

Cell-free DNA profiling informs all major complications of hematopoietic cell transplantation

March 26, 2023

Santersus AG Presented at transCampus Partnership Event in London

March 26, 2023

Page1 Page2 Page3 Page4

CONTACT US

Santersus AG,
c/o Lex Futura AG, Schützengasse 4
8001 Zürich, Switzerland

+ 41 44 586 3656
info@santersus.com

LEGAL

View our full disclaimer